This article has been updated to report the total amount of funding in the round.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – FluimediX today said that it has closed a round of financing intended to support further development of its NanoCycler platform.

The Taastrup, Denmark-based firm raised DKK 6 million ($1.1 million) in the round that was led by Seed Capital Denmark. In addition, existing shareholders participated in the round.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.